These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 746135)

  • 21. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness of radioactive iodine in the treatment of toxic adenoma: results of our experience with a group of 17 patients and review of the literature].
    Melián E; Cuellar L; Estopiñán V; Riobó P; Lara JI; Sánchez-Franco F
    Med Clin (Barc); 1988 Mar; 90(9):366-8. PubMed ID: 3292865
    [No Abstract]   [Full Text] [Related]  

  • 23. [Iodine-125 in treatment of hyperthyreosis (author's transl)].
    Glanzmann C; Piroth HD; Magdeburg W; Horst W
    Radiol Clin Biol; 1974; 43(4):344-7. PubMed ID: 4827304
    [No Abstract]   [Full Text] [Related]  

  • 24. [The influence of radioiodine therapy on the content of sulphhydryl groups in blood serum in toxic struma (author's transl)].
    Livergant JE; Semenov VD; Tarchanova MV
    Radiobiol Radiother (Berl); 1976; 17(6):691-8. PubMed ID: 1019318
    [No Abstract]   [Full Text] [Related]  

  • 25. [Radiotherapy of struma maligna].
    Engelken G; Hymmen U; Schenck P; Wieland C
    Chirurg; 1976 Aug; 47(8):435-8. PubMed ID: 821730
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of radioiodine therapy of manifest hyperthyroidism and autonomous struma with euthyroidism].
    Berding G; Schicha H
    Nuklearmedizin; 1990 Aug; 29(4):158-65. PubMed ID: 2216811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Volume reduction of the thyroid after radioiodine therapy in patients with autonomous goiter and Basedow's goiter].
    Dederichs B; Otte R; Klink JE; Schicha H
    Nuklearmedizin; 1996 Oct; 35(5):164-9. PubMed ID: 9005412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reduction in thyroid gland size due to radioactive iodine in patients with a large goiter].
    Huysmans D; Hermus A
    Ned Tijdschr Geneeskd; 1991 Aug; 135(32):1425-8. PubMed ID: 1922448
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of diffuse hyperthyroidism using radioactive iodine].
    Latković I; Krpan N; Simonović I
    Lijec Vjesn; 1975 Feb; 97(2):72-7. PubMed ID: 1174256
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship of the thyroid scintiscan to the therapeutic effects of 131I in hyperthyroidism with diffuse goiter.
    Tjoe SL; Levine B; Wieland RG; Chen JC
    J Nucl Med; 1971 Dec; 12(12):804-7. PubMed ID: 5118350
    [No Abstract]   [Full Text] [Related]  

  • 31. Incidence of hypothyroidism more than twenty years after therapy in hyperthyroid patients treated with radioactive iodine.
    Ronga G; Esposito M; Baschieri I; Fenzi GF; Martino E; Pinchera A
    J Nucl Med Allied Sci; 1988; 32(4):231-3. PubMed ID: 3230408
    [No Abstract]   [Full Text] [Related]  

  • 32. [Percutaneous radiotherapy of malignant tumors of the thyroid (author's transl)].
    Scherer E
    Rontgenblatter; 1975 Dec; 28(12):580-6. PubMed ID: 814608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability of the administered radioiodine doses for the treatment of hyperthyroidism in Belgium.
    Tondeur M; Glinoer D; Sand A; Verelst J; Ham H
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):206-9. PubMed ID: 16886961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation between drug and surgical methods of treatment of diffuse toxic goiter (15 years of experience of the endocrinology service of Chelyabinsk oblast].
    Levit ID; Sizonenko IA
    Ter Arkh; 1988; 60(9):116-8. PubMed ID: 3217866
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dose calculation for thyroid radiation therapy according to MIRD recommendations (author's transl)].
    Tautz M
    Radiobiol Radiother (Berl); 1976; 17(1):71-5. PubMed ID: 935371
    [No Abstract]   [Full Text] [Related]  

  • 36. [Problems in I-131 therapy of inoperable euthyroid goiter].
    Löbe J
    Radiobiol Radiother (Berl); 1966; 7(1):1-6. PubMed ID: 5947712
    [No Abstract]   [Full Text] [Related]  

  • 37. Thyroid gland suppressibility in patients treated with radioiodine for diffuse toxic goiter.
    Burgos FL; Micames C; Rivera JV
    Bol Asoc Med P R; 1983 Apr; 75(4):173-5. PubMed ID: 6575791
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypothyroidism caused by radioiodine therapy].
    Miclulţia M; Derevenco V; Holan T
    Stud Cercet Endocrinol; 1972; 23(4):263-9. PubMed ID: 4681800
    [No Abstract]   [Full Text] [Related]  

  • 39. External dose rates in radioiodine treatment of benign goitre: estimation versus direct measurement.
    Jørgensen HB; Høilund-Carlsen PF; Nielsen VE
    Scand J Clin Lab Invest; 2006; 66(6):509-16. PubMed ID: 17000558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study.
    Fast S; Nielsen VE; Grupe P; Bonnema SJ; Hegedüs L
    J Nucl Med; 2009 May; 50(5):732-7. PubMed ID: 19403877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.